Journal Guide

Discover the latest in basic and applied research in the analytical sciences related to foods, drugs, agriculture, and the environment. Read contributions from leaders in the fields of chemical and biological analysis, original collaborative studies of AOAC Official MethodsSM, special guest editor sections, invited reviews, and much more.The Journal of AOAC INTERNATIONAL publishes 6 issues per year of fully refereed contributed papers in the fields of chemical and biological analysis: on original research on new techniques and applications, collaborative studies, authentic data of composition, studies leading to method development, meeting symposia, newly adopted AOAC approved methods and invited reviews. To view Journal table of contents and abstracts, click here. (You will be redirected to Atypon, our online host.).

The Journal of Antibiotics seeks to promote research on antibiotics and related types of medicinal substances. The journal will accept biochemical, chemical, microbiological and pharmacological studies. However, studies regarding human therapy do not fall under the journal's scope. Contributions regarding antibiotics and bioactive microbial products are particularly encouraged. Topics of particular interest within the journal's scope include, but are not limited to, those listed below: * Discovery of new antibiotics and related microbial products * Production, isolation, characterization, structural elucidation, chemical synthesis and derivatization, biological activities, mechanisms of action, and structure-activity relationships of antibiotics and related microbial products * Biosynthesis, bioconversion, taxonomy and genetic studies on producing microorganisms, as well as improvement of production of antibiotics and related microbial products * Novel physical, chemical, biochemical, microbiological or pharmacological methods for detection, assay, determination, structural elucidation and evaluation of antibiotics and related microbial products * Newly found properties, mechanisms of action and resistance-development of antibiotics and related microbial productsThe Journal of Antibiotics's original articles cover new theories and primary research. The journal also publishes regular short reviews, book reviews, and news and commentary articles.

The Journal of Antimicrobial Chemotherapy is among the foremost international journals in antimicrobial research. Our readership includes representatives of academia, industry and health services, and includes those who are influential in formulary decisions.Published monthly, the Journal features original articles on the laboratory aspects and clinical use of antimicrobials including antibacterial, antiviral, antifungal, and antiprotozoal agents.In addition to the wealth of primary papers, the journal carries review articles offering in-depth discussion on matters of topical concern. Lively leading articles offer incisive coverage of recent advances and controversies.Other sections include: * For debate: International comment on contentious issues and ideas * Antimicrobial practice: Articles on practical prescribing and formulary issues * Correspondence: A section for scientists to present early observations of their work and to comment on published articles * Book reviews: Helpful reviews of relevant, newly published titles A carefully organised format directs you to areas of interest.Monthly issues can include up to ten informative sections: * Leading articles * Reviews * The Garrod Lecture * For debate * Original articles * Brief reports * Antimicrobial practice * Meeting reports * Correspondence * Book reviews The Journal publishes between two and eight supplements each year. These include Working Party reports of the British Society for Antimicrobial Chemotherapy, and original publications on pre-clinical and clinical aspects of drugs in development or the role of established drugs in specific therapeutic areas.

The Journal of Asian Natural Products Research (JANPR) publishes chemical and pharmaceutical studies in the English language in the field of natural product research on Asian ethnic medicine. The journal publishes work from scientists in Asian countries, e.g. China, Japan, Korea and India, including contributions from other countries concerning natural products of Asia. The journal is chemistry-orientated. Major fields covered are: isolation and structural elucidation of natural constituents (including those for non-medical uses), synthesis and transformation (including biosynthesis and biotransformation) of natural products, pharmacognosy, and allied topics. Biological evaluation of crude extracts are acceptable only as supporting data for pure isolates with well-characterized structures.All published research articles in this journal have undergone rigorous peer review, based on initial editor screening and anonymized refereeing by at least two expert referees. STARTaylor & Francis/Routledge are committed to the widest possible dissemination of its journals to non-profit institutions in developing countries. Our STAR initiative offers individual researchers in Africa, South Asia and many parts of South East Asia the opportunity to gain one month's free online access to 1,300 Taylor & Francis journals. For more information, please visit the STAR website. DisclaimerTaylor & Francis makes every effort to ensure the accuracy of all the information (the "Content") contained in its publications. However, Taylor & Francis and its agents and licensors make no representations or warranties whatsoever as to the accuracy, completeness or suitability for any purpose of the Content and disclaim all such representations and warranties whether express or implied to the maximum extent permitted by law. Any views expressed in this publication are the views of the authors and are not the views of Taylor & Francis.

The Journal of Biomolecular Screening (JBS) is the leading peer-reviewed journal focusing on drug discovery sciences. JBS publishes information that enables researchers to evaluate current technologies and incorporate applications to enhance performance and objectives. Manuscripts and editorial commentary emphasize scientific and technical applications and advances in target identification/validation; lab automation and robotics; high-throughput screening (HTS); lead generation/optimization; virtual screening, chemoinformatics; diagnostic assays; assay development; assay technologies (novel applications, comparisons); data/image analysis, statistics and information technologies/methods; high content screening, imaging platforms; sample management (library design, compound logistics, chemical diversity); biological reagent production, characterization and management for drug discovery (cell lines, stem cells, surrogate tissues/species [xenopus, zebrafish, yeast]); genomic, proteomic screening; biomarkers; high throughput approaches to PK, ADME and predictive toxicology; legal, licensing issues.This publication will be of particular interest to those involved in analytical chemistry, applied microbiology, automation, biochemistry, bioengineering, biomedical optics, biotechnology, bioinformatics, cell biology, DNA science and technology, genetics, information technology, medicinal chemistry, molecular biology, natural products chemistry, organic chemistry, pharmacology, spectroscopy, and toxicology.

The Journal of Biopharmaceutical Statistics, a rapid publication journal, discusses quality applications of statistics in biopharmaceutical research and development. Now publishing six times per year, it includes expositions of statistical methodology with immediate applicability to such work in the form of full-length and short manuscripts, review articles, selected/invited conference papers, short articles, and letters to the editor. Addressing timely and provocative topics important to the biostatistical profession, the journal covers: * drug, device, and biological research and development * drug screening and drug design * assessment of pharmacological activity * pharmaceutical formulation and scale-up * preclinical safety assessment * bioavailability, bioequivalence, and pharmacokinetics * phase, I, II, and III clinical development * premarket approval assessment of clinical safety * postmarketing surveillance Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.

The Journal of Cardiovascular Pharmacology is the leading publication devoted exclusively to important advances in cardiovascular drug research and use. Each monthly issue provides the most up-to-date information on physiological and pharmacological bases of drug action, metabolism, drug interaction, side effects, and clinical results with both new and established drugs.Website: www.jcvp.org.

DON'T MISS A BEAT!Every informative issue of the Journal of Cardiovascular Pharmacology and Therapeutics (JCPT) offers cardiologists, clinical pharmacologists and researchers involved in disease relevant clinical and experimental investigations of newer cardiovascular drugs and other therapeutic options. Four times a year, JCPT examines and analyzes arenas such as: o Agents that Reduce Myocardial Infarct Size o Agents that Reduce Myocardial Remodeling o Angiotensin Converting Enzyme Inhibitors o Antihypertensive Therapy o Arrhythmias o Atrial Fibrillation o Beta-Blocker Therapies o Cardioembolic Stroke o Cardiomyopathy o Cardioprotective Agents o Cardiopulmonary Resuscitation o Cardiovascular Combination Therapies o Chronic Angina o Chronic Cardiac Ischemia o Congestive Heart Failure o Coronary Artery Disease o Coronary Revascularization o Heparin Therapies o Hypertension o Hypotension o Implantable Devices o Ischemic Heart Disease o Myocardial Infarction o Percutaneous Coronary Interventions o Peripheral Arterial Disease o Preconditioning/Postconditioning o Regenerative Cardiology o Stem Cell TherapyAmong the drug classes regularly evaluated are: ACE inhibitors * angiotensin receptor blockers * anti-anginals * anti-arrhythmics * anti-coagulants * anti-hypertensives * anti-thrombins * beta-blockers * calcium channel blockers * cardioprotective agents * cardiotonic agents * direct renin inhibitors * diuretics * fibrinolytic agents * heart rate modulats * plasminogen activators * QT prolonging drugs * statins * vasoconstrictor agents * and vasodilator agents.The journal features original articles, topical journal supplements, reviews, clinical and experimental investigations, and commentaries written by respected practitioners from all over the world.

SUBSCRIBE TO THE Journal of Chemotherapyto help keep you up-to-date on antimicrobial chemotherapy,anticancer chemotherapy, immunomodulating chemotherapy,experimental and clinical studies in these fields published bimonthly.

Journal of Enzyme Inhibition and Medicinal Chemistry is an international and interdisciplinary vehicle publishing new knowledge and findings on enzyme inhibitors and inhibitory processes and agonist/antagonist receptor interactions in the development of medicinal and anti-cancer agents and an understanding of their action.The Journal will publish research papers, short communications and reviews on current developments in enzymology, cell biology, chemical biology, microbiology, physiology, pharmacology leading to drug design, molecular recognition processes and distribution and metabolism of biologically active compounds. Among the various fields of study, special attention is given to structure and molecular aspects, enzyme kinetics and inactivation mechanisms, structure-activity relationships (QSAR, graphic techniques), drug development studies, drug release and control mechanisms in metabolic processes.Read More: http://informahealthcare.com/page/enz/Description.

The Journal of Ethnopharmacology is dedicated to the exchange of information and understandings about people's use of plants, fungi, animals, microorganisms and minerals and their biological and pharmacological effects based on the principles established through international conventions. Early people confronted with illness and disease, discovered a wealth of useful therapeutic agents in the plant and animal kingdoms. The empirical knowledge of these medicinal substances and their toxic potential was passed on by oral tradition and sometimes recorded in herbals and other texts on materia medica. Many valuable drugs of today (e.g., atropine, ephedrine, tubocurarine, digoxin, reserpine) came into use through the study of indigenous remedies. Chemists continue to use plant-derived drugs (e.g., morphine, taxol, physostigmine, quinidine, emetine) as prototypes in their attempts to develop more effective and less toxic medicinals.In recent years the preservation of local knowledge, the promotion of indigenous medical systems in primary health care, and the conservation of biodiversity have become even more of a concern to all scientists working at the interface of social and natural sciences but especially to ethnopharmacologists. Recognizing the sovereign rights of States over their natural resources, ethnopharmacologists are particularly concerned with local people's rights to further use and develop their autochthonous resources.Accordingly, today's ethnopharmacological research embraces the multidisciplinary effort in the:• documentation of indigenous medical knowledge,• scientific study of indigenous medicines in order to contribute in the long-run to improved health care in the regions of study, as well as• search for pharmacologically unique principles from existing indigenous remedies.The Journal of Ethnopharmacology publishes original articles concerned with the observation and experimental investigation of the biological activities of plant and animal substances used in the traditional medicine of past and present cultures. The journal will particularly welcome interdisciplinary papers with an ethnopharmacological, an ethnobotanical or an ethnochemical approach to the study of indigenous drugs. Reports of anthropological and ethnobotanical field studies fall within the journal's scope. Studies involving pharmacological and toxicological mechanisms of action are especially welcome. Clinical studies on efficacy will be considered if contributing to the understanding of specific ethnopharmacological problems. The journal welcomes review articles in the above mentioned fields especially those highlighting the multi-disciplinary nature of ethnopharmacology. Commentaries are by invitation only.

The journal is devoted to the rapid publication of innovative preclinical investigations on therapeutic agents against cancer and pertinent findings of experimental and clinical oncology. In the journal you will find review articles, original articles, and short communications on all areas of cancer research, including but not limited to preclinical experimental therapeutics; anticancer drug development; cancer biochemistry; biotechnology; carcinogenesis; cancer cytogenetics; clinical oncology; cytokine biology; epidemiology; molecular biology; pathology; pharmacology; tumor cell biology; and experimental oncology. Papers concerning work on humans must comply with the principles of the declaration of Helsinki (1964). The approval of an ethical committee must then be stated on the manuscript. The editors reserve the right to reject a paper with questionable ethical justification.

The Journal of Food and Drug Analysis (JFDA) is the official peer-reviewed publication of the Food and Drug Administration, Taiwan (TFDA). It is published quarterly by Elsevier in March, June, September and December, and indexed in Abstracts of Chinese Medicines, Biochemistry & Biophysics Citation Index, BIOSIS Previews, Chemical Abstracts Service, EMBASE, International Food Information Service (FSTA), Research Alert, Science Citation Index Expanded, ScienceDirect and SCOPUS.The JFDA is an international journal that is dedicated to publishing original research and review papers on the analyses of food, drugs, medical devices, cosmetics and traditional Chinese medicine as well as related disciplines that are of topical interest to the public health profession. The goal of the Journal is to provide a platform for scientists and academicians all over the world to promote, share, and discuss new issues and developments in the different areas of analysis.The scope of the Journal includes analytical methodologies, policy analyses, risk analyses and behavioral analyses in relation to food, drugs, medical devices, cosmetics and traditional Chinese medicine. Contributions may be in the form of review articles, original articles, case reports or research notes that have not been published and are not under consideration for publication elsewhere.

The Journal of Herbs, Spices & Medicinal Plants is an essential reference filled with recent research and other valuable information associated with herbs, spices, and medicinal plants. The Journal serves as a focus point through which investigators and others may publish material of importance to the production, marketing, and utilization of these plants and associated extracts. The journal covers the following topics: growth, development, horticulture, ecology, physiology, genetic, chemistry, and economics. Original articles, review articles, and book reviews provide information of interest to an international audience of researchers, teachers, technicians, and managers involved with production and/or marketing of herbs, spices, and medicinal plants. Managers of food companies, food processing facilities, medical research laboratories, government agencies, and others interested in new chemicals, food additives, international trade, patents, and other items can easily review new findings. The Journal of Herbs, Spices & Medicinal Plants is a forum in which recent research and other information associated with herbs, spices, and medicinal plants is shared. The Journal represents a centralized database accessible by investigators within the international community that work with or have an interest in herbs, spices, and medicinal plants. Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.

The Journal of Immunotherapy publishes basic scientific and clinical studies of the immunologic response to tumors and other diseases. It addresses the latest advances in basic cytokine research (interferons, interleukins, and newly described factors); immune regulation; immune response to diseases and associated antigens; growth factors and their receptors; hematopoietic factors; monoclonal antibodies; therapeutic studies in animal models; immunotherapy research, including active immunization and adaptive immunotherapy in animal models and humans; and clinical trials. 160;.